Vertex Pharmaceuticals Incorporated (VRTX)

Nasdaq · Healthcare · Biotechnology
$515.02-1.08%As of 2026-11-22 · USD
Last session low $513.80Last session high $531.37
52-week low $412.2752-week high $568.67
Market cap
$130.58B
Sector
Healthcare
P/E (TTM)
33.1x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)42.8In the neutral range (30 to 70)
MACD (12, 26, 9)1.65Below its signal line (5.20); histogram -3.55
Bollinger %B (20, 2)1%Inside the bands (514.78 to 561.73)
SMA 20538.25Price is 4.3% below
SMA 50522.81Price is 1.5% below
SMA 200484.91Price is 6.2% above
ATR (20)2.90% of priceAverage true range per day
52-week position66%In the middle of the 412.27 to 568.67 range

About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain.

Latest fiscal yearEnded 2025-12-31: revenue of $12.00B and an operating margin of 37.9%.

More in Biotechnology